Asthma

LOUISVILLE, Ky. — Patients experienced fewer asthma exacerbations after taking tezepelumab for 12 months compared with the 12 months prior to treatment, according to study results.

LOUISVILLE, Ky. — Patients treated with albuterol and budesonide experienced less asthma deteriorations and exacerbations over 12 weeks compared with patients who received the mono-components or placebo, according to DENALI study results.

LOUISVILLE, Ky. — Of approved biologics for severe, allergic asthma, tezepelumab was the only one to consistently reduce the annualized exacerbation rate across patient subgroups, according to a literature review.

LOUISVILLE, Ky. — Much like exercise-induced asthma, sexual intercourse can also trigger asthma exacerbations, according to study results presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The FDA’s Pulmonary-Allergy Drug Advisory Committee voted 16-1 in favor of approving the fixed-dose combination of budesonide and albuterol sulfate metered dose inhaler for patients with asthma aged 18 years and older.

Individuals with low FEV1/FVC ratio plus low FVC lifetime trajectories were at an increased risk for COPD, according to a study in The Lancet Respiratory Medicine.

The prevalence of chronic rhinosinusitis with nasal polyps grew in Finland from 2012 to 2019, with asthma increasing patients’ need for corticosteroids and surgery, according to a study published in Clinical and Translational Allergy.

Healio compiled the most-read news in pulmonology posted in October.

Healio compiled the most-read news in allergy, asthma and immunology posted in October.

NASHVILLE, Tenn. — Intestinal fungal dysbiosis was associated with asthma severity, particularly hospital use in the previous year, with severity possibly exacerbated by crosstalk between the gut and the lung, according to study results.